Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANTI-INHIBITOR COAGULANT COMPLEX for Factor ix deficiency: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where ANTI-INHIBITOR COAGULANT COMPLEX was used for Factor ix deficiency.

Most Reported Side Effects for ANTI-INHIBITOR COAGULANT COMPLEX

Side Effect Reports % Deaths Hosp.
Haemorrhage 380 26.4% 19 55
Treatment failure 135 9.4% 0 1
Drug ineffective 129 9.0% 14 26
Therapy partial responder 104 7.2% 72 21
Haemarthrosis 92 6.4% 3 31
Acquired haemophilia 77 5.4% 75 24
Pre-existing disease 74 5.2% 74 22
Death 59 4.1% 59 4
Factor viii inhibition 56 3.9% 3 21
Anti factor viii antibody positive 49 3.4% 2 6
Joint swelling 45 3.1% 0 21
Arthralgia 44 3.1% 0 15
Haematoma 40 2.8% 2 18
Fall 38 2.6% 3 20
Muscle haemorrhage 36 2.5% 2 17

Other Indications for ANTI-INHIBITOR COAGULANT COMPLEX

Haemophilia (335) Factor viii deficiency (317) Acquired haemophilia (215) Product used for unknown indication (213) Prophylaxis (122) Haemorrhage (116) Haemorrhage prophylaxis (56) Post procedural haemorrhage (48) Haemophilia a with anti factor viii (44) Haemostasis (32)

Other Drugs Used for Factor ix deficiency

EFTRENONACOG ALFA (1,133) COAGULATION FACTOR IX RECOMBINANT HUMAN (758) COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL (559) COAGULATION FACTOR IX HUMAN (42) COAGULATION FACTOR VIIA RECOMBINANT HUMAN (36) COAGULATION FACTOR IX , GLYCOPEGYLATED (27) BENEFIX (17) ETRANACOGENE DEZAPARVOVEC (8) ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (7) RITUXIMAB (6)

Related Pages

ANTI-INHIBITOR COAGULANT COMPLEX Full Profile All Factor ix deficiency Drugs ANTI-INHIBITOR COAGULANT COMPLEX Demographics ANTI-INHIBITOR COAGULANT COMPLEX Timeline